Pregnancy and Hereditary Antithrombin Deficiency: New Study Reveals Critical Clearance Peaks at Delivery
Thrombosis Update published on its X:
“A new case study in Thrombosis Update on hereditary antithrombin deficiency (HATD) in pregnancy shows antithrombin clearance increases in the first and third trimesters, peaking around delivery.”
Title: Antithrombin supplementation to prevent venous thromboembolism: A case of hereditary antithrombin deficiency with increased antithrombin clearance during pregnancy and peripartum
Autors: Ayako Kaneda Takeuchi, Tomoaki Oda, Mei Kitamoto , Emiyu Fujiwara, Kenta Kawai, Megumi Narumi, Yoshimasa Horikoshi, Masako Matsumoto, Yukiko Kohmura-Kobayashi, Naomi Furuta-Isomura, Toshiyuki Uchida, Kazunao Suzuki, Naohiro Kanayama, Hiroaki Itoh, Naoaki Tamura.
Two-Sentence Summary (Analytical): A newly published case study highlights that antithrombin clearance significantly increases during the first and third trimesters in pregnant women with hereditary antithrombin deficiency (HATD), peaking around the time of delivery. These findings emphasize the need for dynamic monitoring of antithrombin levels throughout pregnancy to prevent thromboembolic complications in this high-risk population.
You can explore more detailed information on Hemostasis Today.
-
Dec 12, 2025, 23:51Don’t Miss: IACH Post ASH 2025 Roundtable Debate
-
Dec 12, 2025, 23:37C-Reactive Protein and Cardiovascular Risk in the General Population: A European Heart Journal Study by Berkan Kurt et al.
-
Dec 12, 2025, 23:23Alta Schutte and Colleagues at National Hypertension Taskforce: Driving Single-Pill Therapy for Hypertension and More
-
Dec 12, 2025, 22:27Normal Counts, High Risk: Abdul Mannan Breaks Down JAK2 + Splanchnic Vein Thrombosis
-
Dec 12, 2025, 14:478 Posts Not to Miss From the ASH 2025 – Marc Carrier
-
Dec 12, 2025, 10:17Alyssa George on Clinical and Economic Impact of a Eptacog Beta
-
Dec 12, 2025, 09:53Ivan Budnik Awarded AHA Postdoctoral Fellowship! Aiming to Improve DVT Long-term Outcomes
-
Dec 12, 2025, 09:34Giles Platford on Baby Big: Plasma-Derived Drug Against Infant Botulism
-
Dec 12, 2025, 09:22Matteo Foschi Presents The New Expert Guidance on Minor Ischemic Stroke